Insider Transactions in Q1 2025 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,130
-2.65%
|
$40,470
$19.52 P/Share
|
|
Mar 07
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
4,408
-1.61%
|
$88,160
$20.4 P/Share
|
|
Mar 07
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
22,639
-11.23%
|
$452,780
$20.4 P/Share
|
|
Mar 04
2025
|
Tobin W Juvenal Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,573
-6.65%
|
$122,606
$22.23 P/Share
|
|
Mar 04
2025
|
Tobin W Juvenal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,811
+14.16%
|
-
|
|
Mar 04
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
4,440
-3.17%
|
$88,800
$20.86 P/Share
|
|
Mar 04
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,247
-1.2%
|
$24,940
$20.86 P/Share
|
|
Mar 04
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,576
-6.77%
|
$166,672
$22.23 P/Share
|
|
Mar 04
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,109
+21.75%
|
-
|
|
Mar 04
2025
|
Kristen M Oelschlager Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,640
-2.17%
|
$80,080
$22.23 P/Share
|
|
Mar 04
2025
|
Kristen M Oelschlager Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,811
+7.61%
|
-
|
|
Mar 04
2025
|
Frank Stokes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,448
-11.17%
|
$119,856
$22.23 P/Share
|
|
Mar 04
2025
|
Frank Stokes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,186
+19.99%
|
-
|
|
Feb 20
2025
|
Frank Stokes Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,046
-18.55%
|
$209,196
$26.7 P/Share
|
|
Feb 05
2025
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,867
-100.0%
|
$220,276
$28.17 P/Share
|
|
Jan 13
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
1,579
-0.72%
|
$44,212
$28.55 P/Share
|
|
Jan 13
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
986
-0.4%
|
$27,608
$28.55 P/Share
|
|
Jan 07
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
388
-0.52%
|
$11,640
$30.14 P/Share
|
|
Jan 07
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
243
-0.3%
|
$7,290
$30.14 P/Share
|
|
Jan 06
2025
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,867
-19.77%
|
$228,143
$29.21 P/Share
|
|
Jan 06
2025
|
Tobin W Juvenal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,230
-3.09%
|
$66,900
$30.0 P/Share
|
|
Jan 06
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
4,343
-1.86%
|
$125,947
$29.24 P/Share
|
|
Jan 06
2025
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,715
-1.08%
|
$78,735
$29.24 P/Share
|